Legend Biotech Corp (LEGN) — Cash Flow-to-Debt Ratio
Legend Biotech Corp (LEGN) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of $-105.64 Million could theoretically repay 0% of its total liabilities ($723.60 Million) in one year. See Legend Biotech Corp free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Legend Biotech Corp Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Legend Biotech Corp across 9 annual periods. Also explore LEGN net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Legend Biotech Corp (2017–2025)
Year-by-year debt coverage analysis for Legend Biotech Corp. For market capitalisation and broader financial context, see LEGN company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-100.47 Million | $723.60 Million | ▲ +39.3% |
| 2024 | -0.23x | $-144.03 Million | $629.61 Million | ▲ +65.3% |
| 2023 | -0.66x | $-393.28 Million | $597.24 Million | ▼ -91.9% |
| 2022 | -0.34x | $-201.28 Million | $586.65 Million | ▲ +38.9% |
| 2021 | -0.56x | $-198.47 Million | $353.52 Million | ▲ +69.2% |
| 2020 | -1.82x | $-223.00 Million | $122.27 Million | ▼ -801.5% |
| 2019 | -0.20x | $-83.06 Million | $410.58 Million | ▼ -127.6% |
| 2018 | 0.73x | $307.68 Million | $420.40 Million | ▲ +7077.7% |
| 2017 | -0.01x | $-2.38 Million | $226.53 Million | — |